ArticleComputational and structural biotechnology journal2025
Graph neural networks in the nephropathological diagnosis of antibody-mediated rejection.
Article in Computational and structural biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antibody-mediated rejection (AMR) is a leading cause of kidney transplant failure, requiring accurate histopathological assessment for diagnosis. This study evaluates graph-based deep learning models for AMR classification using periodic acid-Schiff (PAS)-stained whole slide images (WSIs), with the aim of improving diagnostic accuracy and reproducibility. A multi-institutional dataset of 1193 WSIs from 348 patients was used, where glomeruli, arteries, and cortical tubulointerstitial regions were segmented via deep learning and represented as nodes in graph-structured data. Feature extraction was performed using both supervised and self-supervised methods, and classification was conducted with four graph neural network (GNN) architectures: Graph-Transformer, and the novel SimpleGCN, DenseGCN and SimpleGAT. Patch-wise convolutional and transformer-based classifiers served as baselines. All models were evaluated at both the WSI and biopsy levels using stratified five-fold cross-validation. GNN-based models consistently outperformed patch-wise baselines, with the best glomeruli-only GNN achieving a 5.34 % improvement in WSI-level accuracy (71.00 %) over the strongest baseline. Incorporating additional compartments (arteries and cortex) further improved accuracy to 86.97 % at the WSI level and 89.53 % at the biopsy level, with statistically significant gains confirming the additive value of multi-compartment modeling. Performance varied across feature extractors and graph configurations, underscoring the complexity of optimizing computational pipelines for AMR diagnosis. Overall, graph-based modeling substantially enhances AMR diagnostic performance over conventional approaches, enabling scalable, low-cost and reproducible workflows with minimal expert input. These findings demonstrate the potential of GNNs to support nephropathologists in delivering more consistent and reliable diagnoses, with future work needed to refine feature representations and integrate multimodal data for broader clinical utility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.